Review details mechanisms, clinical uses and limits of tACS across neuropsychiatric disorders
A review led by Prof. Hongxing Wang (Chinese Medical Journal, 5 Apr 2026) summarizes proposed mechanisms and reported clinical uses of tACS across depression, Alzheimer's, schizophrenia and stroke, and calls for larger randomized trials and closed-loop protocols.
23 Apr 2026